Adhd

Researchers estimated that 6%, or one in 16, U.S. adults had an ADHD diagnosis, more than half of whom were diagnosed in adulthood, according to findings published in the CDC’s Morbidity and Mortality Weekly Report.

The combined use of selective serotonin reuptake inhibitors and methylphenidate did not significantly increase adverse event risk among adults with ADHD and comorbid depression, according to a study published in JAMA Network Open.

Patients with past-month exposure to prescription amphetamines used to treat ADHD had higher odds of developing psychosis or mania compared with those without past-month exposure, according to a recent study.

Some groups of children appeared to experience improved mental health symptoms during the COVID-19 pandemic when compared with pre-pandemic conditions, according to a study published in JAMA Network Open.

We have known for a long time that keratoconus has a negative impact on quality of life.

NEW YORK — Youth with autism spectrum disorder and psychiatric comorbidities were more likely to be hospitalized and show greater symptom severity, which led to prolonged hospital stays and higher costs, according to study results.

Many factors have contributed to the recent surge in adult ADHD diagnoses, but the rise is mostly reflective of what has always existed and gone undetected, according to experts.

The FDA has approved Onyda XR extended-release oral suspension for the treatment of ADHD among children aged 6 years and older, according to a press release from Tris Pharma, Inc.

Approximately one in nine children in the United States had ever received an ADHD diagnosis as of 2022, according to research published in the Journal of Clinical Child & Adolescent Psychology.

NEW YORK — A literature review revealed that clinicians more often assigned psychotic and childhood disorder diagnoses to Black vs. white patients, according to a poster presented at the American Psychiatric Association annual meeting.